chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia, Vaccination complication
Clinical narrative: Got really sick; Had a reaction after the 2nd dose; It was rough; High fever; Body aches; Sweating; Bottom of feet hurt; Was real weak; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (Got really sick), VACCINATION COMPLICATION (Had a reaction after the 2nd dose), MUSCULOSKELETAL STIFFNESS (It was rough), PYREXIA (High fever) and MYALGIA (Body aches) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 02B21A, 013AZ(2)1A and 035C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Heart valve operation NOS (Patient had open heart surgery last year prior to moderna vaccine,) since an unknown date. Concurrent medical conditions included Diabetes mellitus insulin-dependent, Thyroid disorder and Hypertension. Concomitant products included INSULIN LISPRO (HUMALOG) for Diabetes mellitus insulin-dependent, ACETYLSALICYLIC ACID (BABY ASPIRIN) for Heart valve operation NOS, BENAZEPRIL for Hypertension, LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder, BRINZOLAMIDE (AZOPT) and DULOXETINE for an unknown indication.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 31-Aug-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (Got really sick), VACCINATION COMPLICATION (Had a reaction after the 2nd dose), MUSCULOSKELETAL STIFFNESS (It was rough), PYREXIA (High fever), MYALGIA (Body aches), HYPERHIDROSIS (Sweating), PAIN IN EXTREMITY (Bottom of feet hurt) and ASTHENIA (Was real weak). At the time of the report, ILLNESS (Got really sick), VACCINATION COMPLICATION (Had a reaction after the 2nd dose), MUSCULOSKELETAL STIFFNESS (It was rough), PYREXIA (High fever), MYALGIA (Body aches), HYPERHIDROSIS (Sweating), PAIN IN EXTREMITY (Bottom of feet hurt) and ASTHENIA (Was real weak) outcome was unknown.            No treatment information was provided.   This case was linked to MOD-2021-307315 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Headache, Myalgia
Clinical narrative: achy all over; bad headache; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (achy all over) and HEADACHE (bad headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No medical history was provided by the reporter .  Concomitant products included PARACETAMOL (TYLENOL) and IBUPROFEN for an unknown indication.    On 02-Sep-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-Sep-2021, the patient experienced MYALGIA (achy all over) and HEADACHE (bad headache). At the time of the report, MYALGIA (achy all over) and HEADACHE (bad headache) outcome was unknown.            Treatment information was not provided
Sex: U
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: I am scheduled to get my second dose on 8SEP2021; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I am scheduled to get my second dose on 8SEP2021) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I am scheduled to get my second dose on 8SEP2021). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (I am scheduled to get my second dose on 8SEP2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was mentioned. No treatment medication was mentioned.
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Skin ulcer haemorrhage, Vaccination site erythema, Vaccination site movement impairment, Vaccination site swelling, Vaccination site ulcer
Clinical narrative: Swollen Injected Arm from shoulder to elbow after 3rd shot; Red Injected Arm from shoulder to elbow after 3rd shot; Sores on the arm from shoulder to elbow after 3rd shot; Sores were bleeding from shoulder to elbow after 3rd shot; Warm to touch from shoulder to elbow after 3rd shot; Felt weak in that arm from shoulder to elbow after 3rd shot; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (Swollen Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ERYTHEMA (Red Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ULCER (Sores on the arm from shoulder to elbow after 3rd shot), SKIN ULCER HAEMORRHAGE (Sores were bleeding from shoulder to elbow after 3rd shot) and VACCINATION SITE WARMTH (Warm to touch from shoulder to elbow after 3rd shot) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 3 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swollen Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ERYTHEMA (Red Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ULCER (Sores on the arm from shoulder to elbow after 3rd shot), SKIN ULCER HAEMORRHAGE (Sores were bleeding from shoulder to elbow after 3rd shot), VACCINATION SITE WARMTH (Warm to touch from shoulder to elbow after 3rd shot) and VACCINATION SITE MOVEMENT IMPAIRMENT (Felt weak in that arm from shoulder to elbow after 3rd shot). At the time of the report, VACCINATION SITE SWELLING (Swollen Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ERYTHEMA (Red Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ULCER (Sores on the arm from shoulder to elbow after 3rd shot), SKIN ULCER HAEMORRHAGE (Sores were bleeding from shoulder to elbow after 3rd shot), VACCINATION SITE WARMTH (Warm to touch from shoulder to elbow after 3rd shot) and VACCINATION SITE MOVEMENT IMPAIRMENT (Felt weak in that arm from shoulder to elbow after 3rd shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Age: 87.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: Swollen Injected Arm from shoulder to elbow after 3rd shot; Red Injected Arm from shoulder to elbow after 3rd shot; Sores on the arm from shoulder to elbow after 3rd shot; Sores were bleeding from shoulder to elbow after 3rd shot; Warm to touch from shoulder to elbow after 3rd shot; Felt weak in that arm from shoulder to elbow after 3rd shot; This spontaneous case was reported by a pharmacist and describes the occurrence of VACCINATION SITE SWELLING (Swollen Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ERYTHEMA (Red Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ULCER (Sores on the arm from shoulder to elbow after 3rd shot), SKIN ULCER HAEMORRHAGE (Sores were bleeding from shoulder to elbow after 3rd shot) and VACCINATION SITE WARMTH (Warm to touch from shoulder to elbow after 3rd shot) in an 87-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Aug-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 3 dosage form. On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swollen Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ERYTHEMA (Red Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ULCER (Sores on the arm from shoulder to elbow after 3rd shot), SKIN ULCER HAEMORRHAGE (Sores were bleeding from shoulder to elbow after 3rd shot), VACCINATION SITE WARMTH (Warm to touch from shoulder to elbow after 3rd shot) and VACCINATION SITE MOVEMENT IMPAIRMENT (Felt weak in that arm from shoulder to elbow after 3rd shot). At the time of the report, VACCINATION SITE SWELLING (Swollen Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ERYTHEMA (Red Injected Arm from shoulder to elbow after 3rd shot), VACCINATION SITE ULCER (Sores on the arm from shoulder to elbow after 3rd shot), SKIN ULCER HAEMORRHAGE (Sores were bleeding from shoulder to elbow after 3rd shot), VACCINATION SITE WARMTH (Warm to touch from shoulder to elbow after 3rd shot) and VACCINATION SITE MOVEMENT IMPAIRMENT (Felt weak in that arm from shoulder to elbow after 3rd shot) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication use was unknown Treatment information was unknown
Sex: U
Vaccine: COVID19
Symptoms: Blood test, Product dose omission issue, Thrombosis, Urticaria
Clinical narrative: Possible blood clot; had severe hives; Greater then 35 days without getting second dose; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Possible blood clot), URTICARIA (had severe hives) and PRODUCT DOSE OMISSION ISSUE (Greater then 35 days without getting second dose) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Possible blood clot), URTICARIA (had severe hives) and PRODUCT DOSE OMISSION ISSUE (Greater then 35 days without getting second dose). At the time of the report, THROMBOSIS (Possible blood clot), URTICARIA (had severe hives) and PRODUCT DOSE OMISSION ISSUE (Greater then 35 days without getting second dose) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood test: possible blood clot (abnormal) possible blood clot.     mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No relevant concomitant medications were reported. No treatment information was reported.  Very limited information regarding this events has been provided at this time.  Event of thrombosis was automatically upgraded as a Serious event as per IME list. However, based on information available and as per medical criteria was classified as Non-serious. Further information is not expected as there is no consent for follow up.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Event of thrombosis was automatically upgraded as a Serious event as per IME list. However, based on information available and as per medical criteria was classified as Non-serious. Further information is not expected as there is no consent for follow up.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Peripheral swelling, Pruritus
Clinical narrative: bit swollen/My arm is bit swollen; arm is red; itchy/My arm is itchy; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (bit swollen/My arm is bit swollen), ERYTHEMA (arm is red) and PRURITUS (itchy/My arm is itchy) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (bit swollen/My arm is bit swollen), ERYTHEMA (arm is red) and PRURITUS (itchy/My arm is itchy). At the time of the report, PERIPHERAL SWELLING (bit swollen/My arm is bit swollen), ERYTHEMA (arm is red) and PRURITUS (itchy/My arm is itchy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea, Pyrexia
Clinical narrative: fever of 102 degrees Fahrenheit; nausea; body aches; This spontaneous case was reported by an other health care professional and describes the occurrence of PYREXIA (fever of 102 degrees Fahrenheit), NAUSEA (nausea) and MYALGIA (body aches) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concurrent medical conditions included Cancer and Penicillin allergy. Concomitant products included DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ), BENAZEPRIL, METOPROLOL, OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]) and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for an unknown indication.   On 28-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 02-Sep-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Jan-2021, the patient experienced PYREXIA (fever of 102 degrees Fahrenheit), NAUSEA (nausea) and MYALGIA (body aches). The patient was treated with IBUPROFEN at a dose of every 6 hours as needed. At the time of the report, PYREXIA (fever of 102 degrees Fahrenheit), NAUSEA (nausea) and MYALGIA (body aches) outcome was unknown.            Other concomitant medication included Emergen-C once daily
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Back pain, Limb discomfort, Myalgia, Pain in extremity
Clinical narrative: stayed up screaming all night with my legs; hurting all over my body; her shoulders hurt; her legs hurt; her back hurt; feet and hands were swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her legs hurt), BACK PAIN (her back hurt), PERIPHERAL SWELLING (feet and hands were swollen), LIMB DISCOMFORT (stayed up screaming all night with my legs) and ARTHRALGIA (her shoulders hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Sep-2021, the patient experienced PAIN IN EXTREMITY (her legs hurt), BACK PAIN (her back hurt), PERIPHERAL SWELLING (feet and hands were swollen) and ARTHRALGIA (her shoulders hurt). On an unknown date, the patient experienced LIMB DISCOMFORT (stayed up screaming all night with my legs) and MYALGIA (hurting all over my body). At the time of the report, PAIN IN EXTREMITY (her legs hurt), BACK PAIN (her back hurt), PERIPHERAL SWELLING (feet and hands were swollen), LIMB DISCOMFORT (stayed up screaming all night with my legs), ARTHRALGIA (her shoulders hurt) and MYALGIA (hurting all over my body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were provided . No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow up received on 07-sep-2021 included reporter contact detail and new events hurting all over my body,stayed up screaming all night with my legs
Sex: F
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: stayed up screaming all night with my legs; hurting all over my body; her shoulders hurt; her legs hurt; her back hurt; feet and hands were swollen; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (her legs hurt), BACK PAIN (her back hurt), PERIPHERAL SWELLING (feet and hands were swollen), LIMB DISCOMFORT (stayed up screaming all night with my legs) and ARTHRALGIA (her shoulders hurt) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 06-Sep-2021, the patient experienced PAIN IN EXTREMITY (her legs hurt), BACK PAIN (her back hurt), PERIPHERAL SWELLING (feet and hands were swollen) and ARTHRALGIA (her shoulders hurt). On an unknown date, the patient experienced LIMB DISCOMFORT (stayed up screaming all night with my legs) and MYALGIA (hurting all over my body). At the time of the report, PAIN IN EXTREMITY (her legs hurt), BACK PAIN (her back hurt), PERIPHERAL SWELLING (feet and hands were swollen), LIMB DISCOMFORT (stayed up screaming all night with my legs), ARTHRALGIA (her shoulders hurt) and MYALGIA (hurting all over my body) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medication were provided . No treatment medication were provided.   Most recent FOLLOW-UP information incorporated above includes: On 07-Sep-2021: Follow up received on 07-sep-2021 included reporter contact detail and new events hurting all over my body,stayed up screaming all night with my legs
Sex: U
Vaccine: COVID19
Symptoms: Back pain, Pain
Clinical narrative: Pain came back, mostly from my lower back down to my feet; Extreme pain over my entire body; This spontaneous case was reported by a consumer and describes the occurrence of BACK PAIN (Pain came back, mostly from my lower back down to my feet) and MYALGIA (Extreme pain over my entire body) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BACK PAIN (Pain came back, mostly from my lower back down to my feet) and MYALGIA (Extreme pain over my entire body). The patient was treated with HYDROCODONE for Adverse event, at an unspecified dose and frequency. At the time of the report, BACK PAIN (Pain came back, mostly from my lower back down to my feet) and MYALGIA (Extreme pain over my entire body) had not resolved.            No Concomitant medication information was reported.   Reporter did not allow further contact
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Feeling abnormal, Mobility decreased, Myalgia
Clinical narrative: itching; Felt bad; nervous; couldn't drive; rash on the same arm of the vaccination; short of breath; sore; tired; kind of felt nauseated; slept for most of the day; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore), FATIGUE (tired), NAUSEA (kind of felt nauseated), SOMNOLENCE (slept for most of the day) and DYSPNOEA (short of breath) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. DS9E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sleep apnea ( I have sleep apnea and I use a CPAP (since 2015/2016)  ) since 2015, Hypertension since 2013 and Type 2 diabetes mellitus since 2013. Concomitant products included HYDROCHLOROTHIAZIDE, METFORMIN, LOSARTAN, METOPROLOL, LATANOPROST, COLLAGEN, ACETYLSALICYLIC ACID (ASPIRIN 81), GLIMEPIRIDE, MULTIVITAMIN [VITAMINS NOS] and VITAMIN D NOS for an unknown indication.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced MYALGIA (sore), FATIGUE (tired), NAUSEA (kind of felt nauseated) and SOMNOLENCE (slept for most of the day). On 06-Sep-2021, the patient experienced DYSPNOEA (short of breath). On 08-Sep-2021, the patient experienced VACCINATION SITE RASH (rash on the same arm of the vaccination). On an unknown date, the patient experienced PRURITUS (itching), FEELING ABNORMAL (Felt bad), NERVOUSNESS (nervous) and MOBILITY DECREASED (couldn't drive). The patient was treated with GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) for Rash, at an unspecified dose and frequency. At the time of the report, MYALGIA (sore), FATIGUE (tired), NAUSEA (kind of felt nauseated), SOMNOLENCE (slept for most of the day), VACCINATION SITE RASH (rash on the same arm of the vaccination), PRURITUS (itching), NERVOUSNESS (nervous) and MOBILITY DECREASED (couldn't drive) outcome was unknown, DYSPNOEA (short of breath) had not resolved and FEELING ABNORMAL (Felt bad) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that she have a History of allergic reaction to Blood Pressure medication.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Nervousness, Pruritus, Somnolence, Vaccination site rash
Clinical narrative: itching; Felt bad; nervous; couldn't drive; rash on the same arm of the vaccination; short of breath; sore; tired; kind of felt nauseated; slept for most of the day; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (sore), FATIGUE (tired), NAUSEA (kind of felt nauseated), SOMNOLENCE (slept for most of the day) and DYSPNOEA (short of breath) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. DS9E21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Sleep apnea ( I have sleep apnea and I use a CPAP (since 2015/2016)  ) since 2015, Hypertension since 2013 and Type 2 diabetes mellitus since 2013. Concomitant products included HYDROCHLOROTHIAZIDE, METFORMIN, LOSARTAN, METOPROLOL, LATANOPROST, COLLAGEN, ACETYLSALICYLIC ACID (ASPIRIN 81), GLIMEPIRIDE, MULTIVITAMIN [VITAMINS NOS] and VITAMIN D NOS for an unknown indication.    On 30-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Aug-2021, the patient experienced MYALGIA (sore), FATIGUE (tired), NAUSEA (kind of felt nauseated) and SOMNOLENCE (slept for most of the day). On 06-Sep-2021, the patient experienced DYSPNOEA (short of breath). On 08-Sep-2021, the patient experienced VACCINATION SITE RASH (rash on the same arm of the vaccination). On an unknown date, the patient experienced PRURITUS (itching), FEELING ABNORMAL (Felt bad), NERVOUSNESS (nervous) and MOBILITY DECREASED (couldn't drive). The patient was treated with GRAMICIDIN, NEOMYCIN SULFATE, POLYMYXIN B SULFATE (NEOSPORINE) for Rash, at an unspecified dose and frequency. At the time of the report, MYALGIA (sore), FATIGUE (tired), NAUSEA (kind of felt nauseated), SOMNOLENCE (slept for most of the day), VACCINATION SITE RASH (rash on the same arm of the vaccination), PRURITUS (itching), NERVOUSNESS (nervous) and MOBILITY DECREASED (couldn't drive) outcome was unknown, DYSPNOEA (short of breath) had not resolved and FEELING ABNORMAL (Felt bad) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient reported that she have a History of allergic reaction to Blood Pressure medication.
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: sweating; body aches; high fever; chills; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating), MYALGIA (body aches), PYREXIA (high fever) and CHILLS (chills) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 015M20A and 030L20A) for COVID-19 vaccination.     The patient's past medical history included Hysterectomy (Patient reported that she had a hysterectomy at 49 years old). Concurrent medical conditions included Cancer (Patient had been a cancer patient twice and was not taking any therapies at the time of the call for cancer).   On 13-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced HYPERHIDROSIS (sweating), MYALGIA (body aches), PYREXIA (high fever) and CHILLS (chills). The patient was treated with PARACETAMOL (TYLENOL) for Fever, at an unspecified dose and frequency. On 15-Mar-2021, HYPERHIDROSIS (sweating), MYALGIA (body aches), PYREXIA (high fever) and CHILLS (chills) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   After 11 hours, patient had chills, body aches, and sweating due to a high fever for 48 hours. Concomitant medications was not provided by the reporter. Treatment information was not provided for all the other events.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19
Clinical narrative: getting covid; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 08-Sep-2021 and was forwarded to Moderna on 08-Sep-2021.    This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (getting covid) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (getting covid). At the time of the report, COVID-19 (getting covid) outcome was unknown.            No concomitant drugs were reported. No treatment information was reported.   Reporter did not allow further contact
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Body temperature, Chills, Headache, Myalgia
Clinical narrative: injection site pain that traveled down arm and to back and neck; sore throat; fever; Awful headache; muscle pain; joint pain; chills; injection site pain that traveled down arm and to back and neck; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (injection site pain that traveled down arm and to back and neck), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever), HEADACHE (Awful headache) and MYALGIA (muscle pain) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Aug-2021.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced PAIN (injection site pain that traveled down arm and to back and neck), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever), HEADACHE (Awful headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and VACCINATION SITE PAIN (injection site pain that traveled down arm and to back and neck). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (injection site pain that traveled down arm and to back and neck), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever), HEADACHE (Awful headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and VACCINATION SITE PAIN (injection site pain that traveled down arm and to back and neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Sep-2021, Body temperature: 100.6 f (High) 100.6 F. On 08-Sep-2021, Body temperature: 101.7 f (High) 101.7 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were not reported.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Oropharyngeal pain, Pain, Pyrexia, Vaccination site pain
Clinical narrative: injection site pain that traveled down arm and to back and neck; sore throat; fever; Awful headache; muscle pain; joint pain; chills; injection site pain that traveled down arm and to back and neck; This spontaneous case was reported by a nurse and describes the occurrence of PAIN (injection site pain that traveled down arm and to back and neck), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever), HEADACHE (Awful headache) and MYALGIA (muscle pain) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 on 20-Aug-2021.    On 07-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Sep-2021, the patient experienced PAIN (injection site pain that traveled down arm and to back and neck), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever), HEADACHE (Awful headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and VACCINATION SITE PAIN (injection site pain that traveled down arm and to back and neck). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN (injection site pain that traveled down arm and to back and neck), OROPHARYNGEAL PAIN (sore throat), PYREXIA (fever), HEADACHE (Awful headache), MYALGIA (muscle pain), ARTHRALGIA (joint pain), CHILLS (chills) and VACCINATION SITE PAIN (injection site pain that traveled down arm and to back and neck) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Sep-2021, Body temperature: 100.6 f (High) 100.6 F. On 08-Sep-2021, Body temperature: 101.7 f (High) 101.7 F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Hyperhidrosis
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of hyperhidrosis (sweating after the 2nd dose/sweated all night) in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# unknown) for COVID-19  immunization. No medical history reported. On an unknown date, patient received the 1st dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient received the 2nd dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced hyperhidrosis (sweating after the 2nd dose/sweated all night). At the time of the report, hyperhidrosis (sweating after the 2nd dose/sweated all night) outcome: unknown. No concomitant medication or treatment information reported.
Sex: F
Vaccine: COVID19
Symptoms: Tooth disorder
Clinical narrative: upcoming scheduled dental surgery; This spontaneous case was reported by a consumer and describes the occurrence of TOOTH DISORDER (upcoming scheduled dental surgery) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TOOTH DISORDER (upcoming scheduled dental surgery). At the time of the report, TOOTH DISORDER (upcoming scheduled dental surgery) outcome was unknown.            The treatment history was not reported. The concomitant medications was not reported. The patient was undergoing dental surgery after both of the doses of The Moderna COVID-19 vaccine.   Most recent FOLLOW-UP information incorporated above includes: On 09-Sep-2021: Follow-up received on 09-sep-21  with event updated, route of administration and gender of patient deleted in the Follow up document.
Sex: F
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: even sicker; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (even sicker) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (even sicker). At the time of the report, ILLNESS (even sicker) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Treatment information was not provided by the reporter.   This case was linked to MOD-2021-315264 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Administered past the 30 day refrigeration time; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administered past the 30 day refrigeration time) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Aug-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administered past the 30 day refrigeration time). On 11-Aug-2021, EXPIRED PRODUCT ADMINISTERED (Administered past the 30 day refrigeration time) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Date refrigerated was on 13APR2021.  Temperature changes (in F): 41 was noted.  Concomitant product use was not provided by reporter.  No treatment information was provided by the reporter.
Age: 33.0
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Pyrexia
Clinical narrative: little tired; nausea; feverish; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (little tired), NAUSEA (nausea) and PYREXIA (feverish) in a 33-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037F21A and 052E21A) for COVID-19 vaccination.     No Medical History information was reported.   On 02-Aug-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Sep-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (little tired), NAUSEA (nausea) and PYREXIA (feverish). At the time of the report, FATIGUE (little tired), NAUSEA (nausea) and PYREXIA (feverish) outcome was unknown.            No concomitants and treatments are provided.  Upon internal review on 25-Oct-2021, Age units(years) populated.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of vaccination site pain (pain at the site of the injection, upper left arm) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch/lot# 019C21A) for COVID-19 immunization. No medical history reported. On Sep 1, 2021, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), intramuscular; 1 dosage form. On an unknown date, patient experienced vaccination site pain (pain at the site of the injection, upper left arm). At the time of the report, vaccination site pain (pain at the site of the injection, upper left arm) outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine), intramuscular: unknown. No concomitant medication or treatment information reported.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Chest discomfort, Dyspnoea, Headache, Migraine, Myalgia
Clinical narrative: Squeezing her chest; Really bad headache; Hurting to breath/can't take a deep breath without it hurting; Headache which turned to migraine; Everything aches to touch, move; nauseated; Vomiting; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Hurting to breath/can't take a deep breath without it hurting), CHEST DISCOMFORT (Squeezing her chest), MIGRAINE (Headache which turned to migraine), PAIN IN EXTREMITY (Soreness in arm) and MYALGIA (Everything aches to touch, move) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Heart disorder.    On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm). On 10-Sep-2021, the patient experienced DYSPNOEA (Hurting to breath/can't take a deep breath without it hurting), MIGRAINE (Headache which turned to migraine), MYALGIA (Everything aches to touch, move), NAUSEA (nauseated) and VOMITING (Vomiting). On 11-Sep-2021, the patient experienced CHEST DISCOMFORT (Squeezing her chest) and HEADACHE (Really bad headache). At the time of the report, DYSPNOEA (Hurting to breath/can't take a deep breath without it hurting), CHEST DISCOMFORT (Squeezing her chest), MIGRAINE (Headache which turned to migraine), PAIN IN EXTREMITY (Soreness in arm), MYALGIA (Everything aches to touch, move), NAUSEA (nauseated), VOMITING (Vomiting) and HEADACHE (Really bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported.  Treatment drugs :Cold ,Flu , Acetaminophen
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Pain in extremity, Vomiting
Clinical narrative: Squeezing her chest; Really bad headache; Hurting to breath/can't take a deep breath without it hurting; Headache which turned to migraine; Everything aches to touch, move; nauseated; Vomiting; Soreness in arm; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (Hurting to breath/can't take a deep breath without it hurting), CHEST DISCOMFORT (Squeezing her chest), MIGRAINE (Headache which turned to migraine), PAIN IN EXTREMITY (Soreness in arm) and MYALGIA (Everything aches to touch, move) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Family history included Heart disorder.    On 09-Sep-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Sep-2021, the patient experienced PAIN IN EXTREMITY (Soreness in arm). On 10-Sep-2021, the patient experienced DYSPNOEA (Hurting to breath/can't take a deep breath without it hurting), MIGRAINE (Headache which turned to migraine), MYALGIA (Everything aches to touch, move), NAUSEA (nauseated) and VOMITING (Vomiting). On 11-Sep-2021, the patient experienced CHEST DISCOMFORT (Squeezing her chest) and HEADACHE (Really bad headache). At the time of the report, DYSPNOEA (Hurting to breath/can't take a deep breath without it hurting), CHEST DISCOMFORT (Squeezing her chest), MIGRAINE (Headache which turned to migraine), PAIN IN EXTREMITY (Soreness in arm), MYALGIA (Everything aches to touch, move), NAUSEA (nauseated), VOMITING (Vomiting) and HEADACHE (Really bad headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medication was reported.  Treatment drugs :Cold ,Flu , Acetaminophen
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effect from third dose; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (side effect from third dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effect from third dose). At the time of the report, VACCINATION COMPLICATION (side effect from third dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medication was not reported. The treatment history was not provided. Patient was immunodeficient and a titer test showed no detectable levels of Ig-m or Ig-g COVID -19 antibodies.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.     On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Feb-2021, the patient experienced COVID-19 (COVID-19). The patient was treated with STEROIDS for Adverse event, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, COVID-19 (COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 03-Feb-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication blood pressure medication, cholesterol medication and seizure medication (unspecified).  Patient called in to report her and her husband received the Moderna vaccine and then were diagnosed with COVID.  Patient had symptoms of scratchy sore throat, headache, low grade fever, loss sense of taste and smell. Patient was treated with an infusion, antibiotic, steroids, Tylenol and cough drops. Patient reports no longer experiencing these symptoms. Patient reported being on medication for blood pressure, cholesterol and seizures.
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Nasal congestion, Nasopharyngitis
Clinical narrative: Breakout case of COVID; 4 days of congestion; 4 days of head cold; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (Breakout case of COVID), NASAL CONGESTION (4 days of congestion) and NASOPHARYNGITIS (4 days of head cold) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.   In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In August 2021, the patient experienced COVID-19 (Breakout case of COVID), NASAL CONGESTION (4 days of congestion) and NASOPHARYNGITIS (4 days of head cold). At the time of the report, COVID-19 (Breakout case of COVID), NASAL CONGESTION (4 days of congestion) and NASOPHARYNGITIS (4 days of head cold) outcome was unknown.            No concomitant medication was mentioned. No treatment medication was mentioned.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: a little swollen in the arm which lasted for an hour or two; This spontaneous case was reported by a consumer and describes the occurrence of PERIPHERAL SWELLING (a little swollen in the arm which lasted for an hour or two) in a 62-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031B21A and 030A21A) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis (psoriatic arthritis for 22 years and has been on 9 different biologic medicines) and Immunocompromised. Concomitant products included IXEKIZUMAB (TALTZ) for Psoriatic arthritis, PREDNISONE and OXYCODONE for an unknown indication.   On 04-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PERIPHERAL SWELLING (a little swollen in the arm which lasted for an hour or two). At the time of the report, PERIPHERAL SWELLING (a little swollen in the arm which lasted for an hour or two) had resolved.            No treatment medication was provided   This case was linked to MOD-2021-318119, MOD-2021-318145 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 14-Sep-2021: Follow Up Received on 14-Sep-2021 contains No New Information On 15-Sep-2021: Follow Up Received on 15-Sep-2021 contains No New Information